| Literature DB >> 31828021 |
Jimmy Choi1, Beth Taylor2, Joanna M Fiszdon3,4, Matthew M Kurtz3,5, Cenk Tek3, Michael J Dewberry6, Lawrence C Haber1, Dana Shagan1, Michal Assaf1,3, Godfrey D Pearlson1,3.
Abstract
Emerging research highlights the potential cognitive benefits of physical exercise (PE) programs for schizophrenia (SCZ). The few recent efficacy studies that examined augmenting cognitive training (CT) with PE suggest superior effects of the combination. The next step is to consider strategies to enhance adherence in real-world settings if this type of combined treatment is going to be effective. We present the first community effectiveness data for PE and CT that included a motivationally-enhancing, self-determined approach to exercise, in lieu of participant payment. Eighty-five outpatients with schizophrenia attending an intensive outpatient program were randomized to 18 h of either (A) self-determined PE regimen with choice from a menu of different activities; (B) tablet-based neurofeedback CT focused on processing speed (PS) and working memory (WM), or (C) a time-matched combination of PE and CT. Assessments were conducted at baseline, post, and follow-up (2 mo). All groups improved in WM from baseline to post, with greatest gains in the PE only group. At follow-up, cognitive gains originally observed in the PE-only group disappeared, while the PE + CT group evidenced improvements in WM and psychotic symptoms. Notably, attrition for PE was only 7%. Our data shows that combining PE and CT leads to lasting effects that are superior to those of either intervention alone. The low PE drop-out rate suggests a self-determined approach to the exercise regimen was tolerable, and may be an important component of future community implementation efforts.Entities:
Keywords: Cognitive training; Motivation; Physical exercise; Schizophrenia
Year: 2019 PMID: 31828021 PMCID: PMC6889253 DOI: 10.1016/j.scog.2019.100147
Source DB: PubMed Journal: Schizophr Res Cogn ISSN: 2215-0013
Fig. 1Study design.
Demographic and baseline clinical characteristics of the three groups.
| PE only | CT only | PE + CT | F value | Significance | |
|---|---|---|---|---|---|
| Age (years) | 34.37 (6.04) | 35.18 (6.72) | 34.47 (7.05) | 0.12 | .88 |
| Education (years) | 11.04 (2.42) | 11.51 (3.02) | 11.60 (3.17) | 0.31 | .73 |
| Male (%) | 59 | 49 | 52 | Chi-sq = 0.93 | .06 |
| Duration of illness (yrs) | 12.37 (6.81) | 12.06 (7.23) | 13.02 (7.97) | 0.12 | .88 |
| Percentage on atypical antipsychotics | 91 | 94 | 91 | Chi-sq = 0.28 | .58 |
| Schizoaffective (%) | 58 | 56 | 55 | Chi-sq = 0.62 | .21 |
| Working memory | |||||
| WAIS WMI | 83.63 (9.05) | 81.48 (10.21) | 81.77 (8.97) | 0.44 | .65 |
| Processing speed | |||||
| WAIS PSI | 74.34 (11.84) | 72.61 (12.35) | 72.88 (11.22) | 0.18 | .84 |
| BPRS (symptoms) | |||||
| Positive factor | 31.34 (9.12) | 29.76 (6.36) | 29.52 (10.02) | 0.37 | .69 |
| Negative factor | 15.98 (6.78) | 13.79 (4.11) | 13.55 (3.43) | 2.05 | .13 |
| Agitation-mania | 14.38 (5.73) | 15.02 (6.34) | 17.18 (6.76) | 0.81 | .12 |
| Depression-anxiety | 18.75 (8.68) | 19.03 (6.21) | 17.27 (7.19) | 0.46 | .63 |
| Total | 60.02 (17.24) | 58.19 (13.39) | 58.46 (19.20) | 0.10 | .91 |
| Completed entire study intervention (%) | 93 | 96 | 93 |
Fig. 2Working memory and processing speed indices and symptoms at baseline, post, and follow-up (2 months).
Point biserial correlation; relationship between high-low baseline motivation and residual changes scores from baseline to post (3 mo).
| Residual change scores | PE | CT | PE + CT | |||
|---|---|---|---|---|---|---|
| Baseline motivation | Low | High | Low | High | Low | High |
| Working memory | 0.04 | 0.16 | 0.02 | 0.22* | 0.15 | 0.26** |
| Processing speed | 0.06 | 0.20* | −0.03 | 0.21* | 0.22* | 0.25* |
| BPRS negative Sx factor | 0.19 | −0.25** | −0.06 | 0.08 | −0.20* | −0.22* |
Median split: Intrinsic Motivation Inventory.